Cargando…
The variable phenotype and low-risk nature of RAS-positive thyroid nodules
BACKGROUND: Oncogenic mutations are common in thyroid cancers. While the frequently detected RAS-oncogene mutations have been studied for diagnostic use in cytologically indeterminate thyroid nodules, no investigation has studied such mutations in an unselected population of thyroid nodules. No long...
Autores principales: | Medici, Marco, Kwong, Norra, Angell, Trevor E., Marqusee, Ellen, Kim, Matthew I., Frates, Mary C., Benson, Carol B., Cibas, Edmund S., Barletta, Justine A., Krane, Jeffrey F., Ruan, Daniel T., Cho, Nancy L., Gawande, Atul A., Moore, Francis D., Alexander, Erik K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528713/ https://www.ncbi.nlm.nih.gov/pubmed/26253102 http://dx.doi.org/10.1186/s12916-015-0419-z |
Ejemplares similares
-
Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes
por: Baca, Sylvan C., et al.
Publicado: (2017) -
The Impact of Hashimoto Thyroiditis on Thyroid Nodule Cytology and Risk of Thyroid Cancer
por: Silva de Morais, Nathalie, et al.
Publicado: (2019) -
Long- versus short-interval follow-up of cytologically benign thyroid nodules: a prospective cohort study
por: Medici, Marco, et al.
Publicado: (2016) -
The Afirma Xpression Atlas for thyroid nodules and thyroid cancer metastases: Insights to inform clinical decision‐making from a fine‐needle aspiration sample
por: Krane, Jeffrey F., et al.
Publicado: (2020) -
Point of Care Measurement of Body Mass Index and Thyroid Nodule Malignancy Risk Assessment
por: Ahmadi, Sara, et al.
Publicado: (2022)